PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3β pathway☆

The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis

John G.F. Cleland · European Heart Journal · 2003 · 1.5K citations · Full text

Medicine, Cardiology, Internal Medicine +16

The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment

Michel Komajda · European Heart Journal · 2003 · 1.2K citations · Full text

Medicine, Cardiology, Internal Medicine +16

Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family

Yibin Wang, Shuang Huang, Valerie P. Sah et al. · Journal of Biological Chemistry · 1998 · 855 citations · Full text

Life Sciences, Cell Biology, Physiology +14

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

Xueliang Du, Takeshi Matsumura, Diane Edelstein et al. · Journal of Clinical Investigation · 2003 · 799 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Activated glycogen synthase-3β suppresses cardiac hypertrophy <i>in vivo</i>

Christopher L. Antos, Timothy A. McKinsey, Norbert Frey et al. · Proceedings of the National Academy of Sciences · 2002 · 477 citations

Life Sciences, Cell Biology, Physiology +16